Get started
Author

Federico Rotolo

Tumor Mutation Burden as a Biomarker in Resected Non–Small-Cell Lung Cancer
2018 · Siddhartha Devarakonda, Federico Rotolo, et al. · Journal of Clinical Oncology · 271
IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial
2019 · Martine Bagot, Pierluigi Porcu, et al. · The Lancet Oncology · 167
PDF
Empirical extensions of the lasso penalty to reduce the false discovery rate in high‐dimensional Cox regression models
2016 · Nils Ternès, Federico Rotolo, et al. · Statistics in Medicine · 122
parfm: Parametric Frailty Models inR
2012 · Marco Munda, Federico Rotolo, et al. · Journal of Statistical Software · 121
Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial
2021 · the Study 1053 investigators, Robert J. Kreitman, et al. · Journal of Hematology & Oncology · 88
PDF
Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis
2016 · Federico Rotolo, Jean-Pierre Pignon, et al. · JNCI Journal of the National Cancer Institute · 87
PDF
Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis
2016 · Béranger Lueza, Federico Rotolo, et al. · BMC Medical Research Methodology · 51
PDF
Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice
2016 · S. Michiels, N. Ternès, et al. · Annals of Oncology · 48
PDF
Ventilator-associated pneumonia and bloodstream infections in intensive care unit cancer patients: a retrospective 12-year study on 3388 prospectively monitored patients
2019 · A. Stoclin, F. Rotolo, et al. · Supportive Care in Cancer · 43
PDF
Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort
2018 · M. Kandel, C. Allayous, et al. · European Journal of Cancer · 42
Identification of biomarker‐by‐treatment interactions in randomized clinical trials with survival outcomes and high‐dimensional spaces
2016 · Nils Ternès, Federico Rotolo, et al. · Biometrical Journal · 41
PDF
Combination of monalizumab and cetuximab in recurrent or metastatic head and neck cancer patients previously treated with platinum-based chemotherapy and PD-(L)1 inhibitors.
2020 · Roger B. Cohen, Jessica Ruth Bauman, et al. · Journal of Clinical Oncology · 40
surrosurv: An R package for the evaluation of failure time surrogate endpoints in individual patient data meta-analyses of randomized clinical trials
2017 · Federico Rotolo, Xavier Paoletti, et al. · Computer Methods and Programs in Biomedicine · 39
Adjuvant cisplatin-based chemotherapy in nonsmall-cell lung cancer: new insights into the effect on failure type via a multistate approach
2014 · F. Rotolo, A. Dunant, et al. · Annals of Oncology · 33
PDF
Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE])*
2022 · Julien Carvelli, Ferhat Meziani, et al. · Critical Care Medicine · 30
Accounting for grouped predictor variables or pathways in high-dimensional penalized Cox regression models
2020 · Shaima Belhechmi, Riccardo De Bin, et al. · BMC Bioinformatics · 30
PDF
A Poisson approach to the validation of failure time surrogate endpoints in individual patient data meta-analyses
2017 · Federico Rotolo, Xavier Paoletti, et al. · Statistical Methods in Medical Research · 25
biospear: an R package for biomarker selection in penalized Cox regression
2017 · Nils Ternès, Federico Rotolo, et al. · Bioinformatics · 24
PDF
A simulation procedure based on copulas to generate clustered multi-state survival data
2012 · Federico Rotolo, Catherine Legrand, et al. · Computer Methods and Programs in Biomedicine · 23
Predictive classifier for intensive treatment of head and neck cancer
2020 · Kaveh Zakeri, Federico Rotolo, et al. · Cancer · 21
PDF
Evaluation of Treatment Effect with Paired Failure Times in a Single-Arm Phase II Trial in Oncology
2018 · Matthieu Texier, Federico Rotolo, et al. · Computational and Mathematical Methods in Medicine · 16
PDF
Genome-wide copy number analyses of samples from LACE-Bio project identify novel prognostic and predictive markers in early stage non-small cell lung cancer
2018 · Federico Rotolo, Chang-Qi Zhu, et al. · Translational Lung Cancer Research · 15
PDF
Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials
2017 · Nils Ternès, Federico Rotolo, et al. · BMC Medical Research Methodology · 13
PDF
123MO Monalizumab, cetuximab and durvalumab in first-line treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): A phase II trial
2021 · D.A. Colevas, K. Misiukiewicz, et al. · Annals of Oncology · 12
PDF
Testing the treatment effect on competing causes of death in oncology clinical trials
2014 · Federico Rotolo, Stefan Michiels · BMC Medical Research Methodology · 12
PDF
Works count: 108
Citation count: 1,471
H-index: 20
I10-index: 25
Year
Topic
Type